AI-Powered Infusion Prior Authorization Services
Outsourced infusion PA team handling submissions against ACR Appropriateness Criteria and payer policies. AAPC-credentialed specialists paired with AI agents. 4-hour standard turnaround.
How we get infusion therapy prior auths through every major payer.
A real look at our infusion therapy PA workflow, AAPC-credentialed PA specialists handling the case.
Tell us your practice. We’ll project your savings in 24 hours.
Single specialty or multi-site? Send us your situation, we map the right Infusion Prior Authorization team.
What Is Infusion Prior Authorization?
Picture a Monday morning at a busy practice. Thirty pending infusion PAs on the queue. Five urgent requests waiting before noon. A peer-to-peer review at 11 a.m. for a denial. That’s the day infusion PA tries to eat.
Infusion prior authorization is the payer’s gate before non-emergent infusion care. outpatient infusion administration for biologics, immunoglobulins, antibiotics, and chemotherapy. Each payer has its own medical necessity policy. Each procedure has its own documentation set.
Staffingly’s AI-powered infusion PA service handles the full workflow. AI agents read the clinical note, pull drug-specific PA, infusion order, monitoring requirements, premedication protocol, and pre-populate the submission. AAPC-credentialed PA specialists review, sign off, and submit through CoverMyMeds, Availity, Carelon, eviCore, and direct payer portals. Standard turnaround is 4 hours. Expedited PAs go out within 60 minutes.
Most infusion practices pair PA with our infusion suite eligibility verification, infusion suite medical billing, and infusion suite credentialing to keep first-pass approval rates high and AR days low.
What Infusion Groups Need to Know About PA in 2026
CMS-0057-F took effect January 1, 2026 for impacted payers: Medicare Advantage, state Medicaid FFS and Managed Care, CHIP FFS and Managed Care, and FFE Qualified Health Plan issuers. Those plans now owe a PA decision within 7 calendar days standard and 72 hours expedited, with a specific denial reason every time. The first public reporting deadline for PA approval and denial metrics was March 31, 2026. Commercial PPO and HMO plans outside this list are not directly bound by the rule, though most are aligning voluntarily.
Infusion physicians average 39 PA requests per week per physician per the 2024 AMA survey, and 31 percent say PAs are often or always denied. When practices appeal, 81.7 percent of denials are fully or partially overturned. That’s a lot of revenue sitting in a workflow most groups under-resource.
Hiring an in-house infusion PA coordinator costs $55K to $84K fully loaded. Staffingly’s outsourced infusion PA service runs $399 per role per week at single tier, $349 at team, $299 at department or enterprise. Live in 5 to 10 days. 2-week risk-free pilot.
Why Infusion PA Eats Days Most Groups Don’t Have
Infusion PA is its own workflow. Each payer has specific medical necessity criteria, typically anchored to ACR Appropriateness Criteria or similar specialty AUC. Each procedure needs the right combination of clinical question, prior workup, and patient-specific indication. Each payer rewrites these annually.
Layer on the peer-to-peer review. The 2024 AMA survey found only 15 percent of physicians say the peer is actually qualified to make the call. That’s an hour of an ordering physician’s day spent explaining clinical criteria to someone outside the specialty.
That’s why mid-size and enterprise infusion practices outsource. Not to cut a coordinator. To stop losing 13 hours of physician time per week to a workflow that doesn’t need a physician.
How Staffingly’s Infusion PA Is Built Different
AI + AAPC-credentialed PA specialists, working inside your EMR. Not portal data entry. Not call-center scripts. A clinical-grade PA team that knows infusion.
AI + Specialist Pairs
AWS Bedrock clinical reasoning agent reads the chart and drafts the medical necessity narrative. An AAPC-credentialed PA specialist reviews, refines, and submits. AI handles 80 percent of keystrokes.
Infusion-Trained
Day-one productive on infusion medical necessity policies across all major payers, ACR Appropriateness Criteria, prior workup documentation, and CPT code selection.
EMR-Native
Works inside Epic, Athena, eClinicalWorks, AdvancedMD, Cerner, NextGen, and Kareo. No screen-share. No data re-entry. Direct EMR access via encrypted VPN with full audit trail.
HIPAA + SOC 2 + ISO 27001
BAA signed before day one. SOC 2 Type II audited. ISO 27001 and HITRUST CSF-aligned controls. Read our HIPAA security posture.
Payer Rules Engine
n8n payer workflow orchestration with CoverMyMeds, Availity, eviCore, Carelon, and direct portal integration. Live policy library for all 12 major payers across infusion service lines.
Peer-to-Peer Prep
We brief your ordering physician 30 minutes before the infusion peer-to-peer call. Clinical question, prior workup, ACR or specialty AUC citation by section. Most infusion peer-to-peers turn into approvals.
Denial Recovery
Every denial gets analyzed by our AI appeal agent. 81.7 percent of appealed denials overturn per the 2024 AMA PA survey. We work that statistic to your favor with structured letters, evidence packs, and IRO escalation when needed.
2-Week Risk-Free Pilot
Scope one workflow (typically nuclear stress or cardiac MRI). 14 days. If the throughput, accuracy, and turnaround don’t hold, you walk away. Most pilots convert to full rollout.
Infusion CPT and HCPCS Codes We Handle
Common infusion CPT codes that trigger PA across commercial, Medicare Advantage, and Medicaid Managed Care. Our specialists know the ACR-anchored documentation for each.
| CPT / HCPCS | Procedure | Typical PA Trigger | Common Documentation |
|---|---|---|---|
| 96365 | Therapeutic IV infusion, initial 1 hour | All payers | Drug PA, infusion plan |
| 96366 | Each additional sequential infusion 1 hour | Bundled | Same encounter |
| 96367 | Sequential drug infusion 1 hour | Bundled | Same encounter |
| 96413 | Chemotherapy IV infusion, initial 1 hour | All payers | Cancer diagnosis, NCCN evidence |
| 96415 | Chemotherapy additional 1 hour | Bundled | Same encounter |
| 96416 | Chemotherapy IV with prolonged infusion | Plan-specific | Continuous infusion documentation |
| J0717 | Certolizumab pegol (Cimzia) infusion | All payers, biologic | RA/IBD documentation |
| J1745 | Infliximab (Remicade) infusion | All payers | Same as biologics |
| J7799 | Unclassified IV biologic | All payers | Drug-specific PA |
| ICD-10 Z51.81 | Encounter for therapeutic drug monitoring | Required pairing | Drug + diagnosis |
Coverage rules change by payer and by plan. Our payer policy library is refreshed monthly across commercial, Medicare Advantage, Medicaid Managed Care, and Tricare.
How a Infusion PA Moves Through Staffingly
Intake from EMR
AI agent pulls the order, clinical note, prior imaging, and demographic data from your EMR within minutes of the order being placed. No staff trigger needed.
AI medical necessity draft
AWS Bedrock matches clinical data to the patient’s payer policy and drafts the medical necessity narrative with citations. Drug-specific pa, infusion order, monitoring requirements, premedication protocol, all in the right format.
Specialist review and submit
An AAPC-credentialed infusion PA specialist reviews the AI draft, fixes anything the agent missed, and submits via CoverMyMeds, Availity, Carelon, eviCore, or the payer portal.
Status monitoring
We poll for status every 4 hours. CMS-0057-F windows kick in for MA, Medicaid MC, and CHIP: 72 hours expedited, 7 days standard. When the decision lands, we route it back into your EMR.
Peer-to-peer prep
If the payer requires P2P, we brief your ordering physician with chart highlights, prior therapy timeline, and specialty-society and FDA label citations 30 minutes before the call. Most P2Ps convert to approval.
Appeals if denied
Denials flow to our appeals agent. Structured letters, evidence packs, IRO escalation if needed. Per the 2024 AMA PA survey, 81.7 percent of appealed denials overturn fully or partially.
An Infusion Denial Overturned for Same-Day Bundle
Representative Scenario · CPT 96365 + 96367 · Aetna Commercial
A 3-infusion suite practice in Ohio (OH) sent us a 3-day-old Aetna denial on CPT 96365 plus 96367 for a 52-year-old patient receiving IV antibiotics for endocarditis (vancomycin + ceftriaxone). The reviewer denied 96367 citing “infusion sequencing not documented.”
Our PA specialist pulled the chart, documented the sequential nature of the two infusions (vancomycin first 1 hour, ceftriaxone second 30 min same IV access), attached the medication administration record, and packaged the CMS infusion billing guidance supporting same-day sequential infusion billing. We briefed the infectious disease specialist 30 minutes before the P2P call.
Outcome: Approval issued during the P2P call. Bundle paid. Total Staffingly time from intake to approved: 3 hours.
Scenario composited from anonymized client workflows. No PHI shown. Outcomes vary by chart strength, payer, and reviewer.
How AI and Automation Make Infusion PA Faster and More Accurate
80 percent automation, 20 percent clinical judgment
Our PA stack pairs AWS Bedrock for clinical reasoning with n8n for payer workflow orchestration. The Bedrock agent reads the chart, pulls the clinical data the payer wants, and matches it to the relevant payer policy. Google Vertex AI classifies supporting documents. For electronic prior auth we route through CoverMyMeds and Surescripts. An AAPC-credentialed PA specialist reviews and signs off before submission. AI handles roughly 80 percent of the keystrokes. Clinical decisions stay with humans.
InsuVerifAI, our proprietary EV+PA SaaS, handles eligibility checks and benefit verification in parallel so the PA team always has live coverage data before submitting. For ePA-enabled drugs and procedures, we route through CoverMyMeds and Surescripts for instant payer responses. Claude 4.5 Haiku powers our voice agent that handles peer-to-peer scheduling and payer status calls.
The result: AI handles roughly 80 percent of the keystrokes on a infusion PA. The AAPC-credentialed PA specialist owns the 20 percent that needs clinical judgment, payer relationship knowledge, or peer-to-peer prep. We never claim fully automated PA, because clinical and compliance decisions still need a human. The combination is what gets us to a 4-hour standard turnaround and an above-industry first-pass approval rate.
One Flat Weekly Rate. No Surprises.
Dedicated prior authorization specialists at a fixed weekly cost. 45 hours per week, fully managed. No contracts, no minimums, no hidden fees.
One prior authorization specialist, single-location practice
5+ specialists, mid-size practice or health system region
10+ specialists, multi-location health system or PE-backed group
All plans include dedicated prior authorization specialists, payer portal access, EMR integration, and a 2-Week Risk-Free Pilot with a signed BAA. No long-term contract required.
Remote Infusion PA, Delivered Across the U.S. and Canada
Our PA specialists work from secured Staffingly facilities in India, Pakistan, and Bangladesh. Every specialist is overseas-licensed and educated in healthcare administration, AAPC-credentialed, and HIPAA-trained before day one. Infusion practices in Texas (TX), Florida (FL), California (CA), New York (NY), New Jersey (NJ), Illinois (IL), Pennsylvania, Ohio (OH), Georgia (GA), North Carolina (NC), Arizona (AZ), and Michigan (MI) run their infusion PA queue with us.
Pair Infusion PA With:
Real-time benefit checks before infusion.
CPT and ICD-10 coding accuracy for infusion.
Payer enrollment for infusion providers.
The AI stack powering our infusion PA and EV workflows.
Related Prior Authorization Services:
Common Questions About Infusion Prior Authorization
What is infusion prior authorization and when is it required?
How does AI-powered infusion prior authorization work?
How long does infusion prior authorization take with Staffingly?
If the May 2026 AMA survey shows only 33% of physicians think insurer PA pledges will change anything, why outsource now (AI-Powered Infusion Prior Authorization Services)?
UHC compressed the peer-to-peer window from 30 days to 14 days. How are practices keeping up (AI-Powered Infusion Prior Authorization Services)?
With PA denials up 31 percent in 2026 and 34 percent of all first-pass denials now PA-related, what’s actually working (AI-Powered Infusion Prior Authorization Services)?
The peer-to-peer reviewer wasn’t qualified for my specialty. What’s the escalation path (AI-Powered Infusion Prior Authorization Services)?
How fast can my practice or imaging center start outsourcing infusion PAs?
Who handles urgent infusion prior authorizations for BCBS?
How do I outsource infusion PAs for my practice?
Can AI submit a infusion PA without a human?
Talk to a real human about your Infusion Prior Authorization
30-minute strategy call. We map your infusion PA volume, payer mix, and EMR setup. No slide deck, just a working plan.
Dan Nandan is the President and CEO of Staffingly, Inc. With 25+ years in IT consulting and healthcare BPO operations, he was one of the earliest U.S. operators to set up an RPO/BPO delivery network in India over 20 years ago. Today his work centers on AI-driven healthcare workflows and helping infusion practices and health systems cut administrative costs without compromising patient care.
Connect on LinkedIn
Bincy Shiiju Kuriakose is a Clinical Content Reviewer at Staffingly and a U.S. Licensed Registered Nurse (MSN, RN). NCLEX-RN certified with expertise in hospital nursing, telehealth, and nursing education. Reviews every service page for clinical accuracy, HIPAA compliance, and evidence-based best practices.
Connect on LinkedInWhere Our Infusion PA Data Comes From
Every stat, threshold, and regulatory window on this page traces back to a primary source. We do not invent numbers.
- CMS Interoperability and Prior Authorization Final Rule (CMS-0057-F). effective dates and decision windows
- 2024 AMA Prior Authorization Physician Survey. 39 PAs per week, denial rates, burnout data
- AMA Prior Authorization Research and Reports. 81.7 percent appeal overturn rate
- CMS Medicare Coverage Database. Medicare infusion billing
- FDA Approved Drugs Database. infusion drug label criteria
- IDSA Practice Guidelines. infectious disease infusion evidence
- ACR Clinical Practice Guidelines. biologic infusion evidence
- KFF Medicare Advantage Prior Authorization Data. MA plan PA volume and denial trends
- MGMA Medical Group Practice Benchmarks. PA staffing and cost benchmarks
- HFMA Revenue Cycle Resources. AR days, denial rates, and PA workflow benchmarks
